Bose, Prithviraj
Alfayez, Mansour
Verstovsek, Srdan
Funding for this research was provided by:
National Cancer Institute (P30 CA016672)
Article History
First Online: 24 January 2019
Compliance with Ethical Standards
:
: Prithviraj Bose has received research funding from Incyte Corporation, Celgene, Blueprint Medicines, Constellation Pharmaceuticals, Kartos Therapeutics, CTI BioPharma, Astellas, and Pfizer, and has received compensation from Incyte Corporation, Celgene, and Blueprint Medicines for service as a consultant.Mansour Alfayez declares that he has no conflict of interest.Srdan Verstovsek has received research support for the conduct of clinical studies from Incyte Corporation, Roche, NS Pharma, Celgene, Gilead, Promedior, CTI BioPharma, Genentech, Blueprint Medicines, and Novartis, and has received compensation from Constellation Pharmaceuticals, Pragmatist, Sierra, Incyte Corporation, Novartis, and Celgene for service as a consultant.
: This article does not contain any studies with human or animal subjects performed by any of the authors.